Doctor profile · Federal record
Dr. Cassie Rose, NP
Family Nurse Practitioner (CMS: Nurse Practitioner) · Bismarck, ND
- NPI 1679911622
- Accepts Medicare
- MIPS 84.0 / 100 · 2023
- 13 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
222 North 7Th Street
Bismarck, ND 585014436
(701) 323-5202
fax (701) 323-5369
Credentials & registration
- NPI registered
- June 2013 — 13 yrs on file
- Profile last updated
- December 23, 2025
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- North Dakota #R35677
- Medicaid
- ND #1450601
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1679911622. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
233
Distinct HCPCS
4
Medicare allowed
$22,788
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 113 | 77 | $99 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 82 | 77 | $108 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 20 | 15 | $66 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 18 | 17 | $81 |
In context: peer comparison
Among 30 peers in this city , average services per provider: 87. This provider delivers 2.7× the peer median.Open Payments
Industry payments received
All-time total
$978
Transactions
58
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $213.56 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $143.28 | |
| PFIZER INC. | 7 | $123.29 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $73.29 | |
| Edwards Lifesciences Corporation | 1 | $72.08 | |
| Lexicon Pharmaceuticals, Inc. | 4 | $69.54 | |
| Kiniksa Pharmaceuticals International, plc | 3 | $62.78 | |
| Merck Sharp & Dohme LLC | 3 | $46.64 | |
| Amgen Inc. | 2 | $39.16 | |
| Janssen Pharmaceuticals, Inc | 2 | $35.79 | |
| United Therapeutics Corporation | 2 | $34.84 | |
| Alnylam Pharmaceuticals Inc. | 2 | $29.70 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18.24 | |
| Boston Scientific Corporation | 1 | $16.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
44
Patients
15
Total drug cost
$597
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 29 | 15 | $440 |
| Metoprolol Succinate | Generic | 15 | 0 | $157 |
Frequently asked questions
What is Dr. Cassie Rose's medical specialty?
Dr. Cassie Rose practices Family Nurse Practitioner in Bismarck, ND.
Where does Dr. Cassie Rose practice?
Dr. Cassie Rose practices at 222 North 7Th Street, Bismarck, ND 585014436. Office phone: 7013235202.
What is Dr. Cassie Rose's NPI?
Dr. Cassie Rose's National Provider Identifier (NPI) is 1679911622, issued by NPPES.
Does Dr. Cassie Rose accept Medicare assignment?
Yes. Dr. Cassie Rose accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Cassie Rose commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233); Initial hospital care with straightforward or low-level medical decision making (HCPCS 99222); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232). Source: CMS Medicare Physician & Other Practitioners file.